Nicholas Livingston, PhD
Nicholas Livingston, PhD

Principal Investigator
Behavioral Science Division
See staff directory for contact information.
Academic Appointment
- Boston University Chobanian & Avedisian School of Medicine, Assistant Professor of Psychiatry
Education
- VA Boston Healthcare System, Boston, MA, VA Interprofessional Advanced Fellowship in Addiction Treatment, 2019
- VA Boston Healthcare System, Boston, MA, Predoctoral Internship, 2017
- University of Montana, Missoula, MT, Clinical Psychology, Ph.D., 2017
- University of Montana, Missoula, MT, Clinical Psychology, M.A., 2014
- University of Utah, Salt Lake City, UT, Summa Cum Laude, Psychology and substance use counseling, B.S., 2010
Expertise and Interests
- Longitudinal course of substance use, PTSD, and their co-occurrence
- Improving PTSD and substance use disorder treatment reach, implementation, and effectiveness
- Prediction and prevention of adverse events (e.g., overdose and suicide death)
- Technology-based interventions
Membership in Professional Societies
- American Psychological Association (APA)
- International Society for Traumatic Stress Studies (ISTSS)
- Association for Behavioral and Cognitive Therapies (ABCT)
- International Network on Brief Interventions for Alcohol & Other Drugs (INEBRIA)
Awards and Honors
- David Shakow Early Career Award for Contributions to Clinical Science (APA)
- Malyon-Smith Research Award (APA, Div. 44)
- Bertha Morton Research Award
Selected Publications
Livingston, N.A., Mandavia, A.D., Banducci, A.N., Sistad Hall, R., Loeffel, L.B., Davenport, M., Mathes-Winnicki, B., Ting, M., Roth, C.E., Sarpong, A., Newberger, N., Hinds, Z., Fonda, J.R., Chen, D., & Meng, F. (in press). Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data. Journal of Psychopathology and Clinical Science.
Livingston, N.A., Mandavia, A.D., Banducci, A.N., Loeffel, L.B., Sistad Hall, R., Maloney, M., Roth, C.E., Fonda, J.R., Davenport, M., Meng, F., Hyde, J., Stein, M. (2024). Emergency department visits, inpatient hospitalizations, and non-fatal and fatal drug overdoses during COVID-19 among Veterans with opioid use disorder. Journal of Studies on Alcohol and Drugs. 10.15288/jsad.24-00184. Advance online publication. https://doi.org/10.15288/jsad.24-00184
Livingston, N.A., Davenport, M., Head, M., Henke, R., Smith LeBeau, L., Gibson, T.B., Banducci, A., Sarpong, A., Jayanthi, S., Roth, C., Camacho-Cook, J., Meng, F., Hyde, J., Mulvaney-Day, N., White, M., Chen, D.C., Stein, M.D., & Weisberg, R. (2022). The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. Drug and Alcohol Dependence, 241, 109678. https://doi.org/10.1016/j.drugalcdep.2022.109678
Livingston, N.A., Farmer, S., Mahoney, C., Marx, B., Keane, T. (2021). Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder. Psychology of Addictive Behaviors, 36(2), 131-143. doi: 10.1037/adb0000736
Livingston, N.A., Lee, D., Mahoney, C., Farmer, S., Cole, T., Marx, B., & Keane, T. (2021). Longitudinal assessment of PTSD and illicit drug use among male and female OEF-OIF veterans. Addictive Behaviors, 118, 106870. https://doi.org/10.1016/j.addbeh.2021.106870